ANGLE plc (ANPCF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 21.35 Million GBP | -64.71% |
| 2022 | 24.82 Million GBP | 38.3% |
| 2021 | 17.94 Million GBP | 25.25% |
| 2020 | 14.32 Million GBP | 14.95% |
| 2019 | 12.46 Million GBP | 9.13% |
| 2018 | 11.42 Million GBP | 21.61% |
| 2017 | 9.39 Million GBP | 20.26% |
| 2016 | 7.81 Million GBP | 36.95% |
| 2015 | 5.7 Million GBP | 47.06% |
| 2014 | 3.87 Million GBP | 11.28% |
| 2013 | 3.48 Million GBP | 36.37% |
| 2012 | 2.55 Million GBP | 2065.72% |
| 2011 | 118 Thousand GBP | -95.86% |
| 2010 | 2.84 Million GBP | -33.75% |
| 2009 | 4.29 Million GBP | -27.64% |
| 2008 | 5.94 Million GBP | -68.4% |
| 2007 | 18.8 Million GBP | 201.75% |
| 2006 | 6.23 Million GBP | -55.58% |
| 2005 | 14.02 Million GBP | 0.0% |
| 2004 | 14.02 Million GBP | 383.16% |
| 2003 | 2.9 Million GBP | 48483.33% |
| 2002 | -6000.00 GBP | -103.24% |
| 2001 | 185 Thousand GBP | 166.79% |
| 2000 | -277 Thousand GBP | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 4.45 Million GBP | -10.65% |
| 2024 Q2 | 4.45 Million GBP | 0.0% |
| 2023 Q1 | 5.68 Million GBP | -56.82% |
| 2023 Q3 | 4.99 Million GBP | -52.44% |
| 2023 Q4 | 4.98 Million GBP | -0.11% |
| 2023 FY | 8.75 Million GBP | -64.71% |
| 2023 Q2 | 10.5 Million GBP | 84.62% |
| 2022 Q4 | 13.17 Million GBP | 96.13% |
| 2022 Q2 | 9.64 Million GBP | 81.46% |
| 2022 Q1 | 5.31 Million GBP | -36.08% |
| 2022 FY | 24.82 Million GBP | 38.3% |
| 2022 Q3 | 6.71 Million GBP | -30.33% |
| 2021 Q1 | 4.44 Million GBP | -42.5% |
| 2021 Q4 | 8.31 Million GBP | 97.69% |
| 2021 Q2 | 8.19 Million GBP | 84.53% |
| 2021 FY | 17.94 Million GBP | 25.25% |
| 2021 Q3 | 4.2 Million GBP | -48.69% |
| 2020 Q2 | 5.26 Million GBP | 128.36% |
| 2020 Q1 | 2.3 Million GBP | 0.0% |
| 2020 FY | 14.32 Million GBP | 14.95% |
| 2020 Q3 | 4.6 Million GBP | -12.58% |
| 2020 Q4 | 7.72 Million GBP | 67.74% |
| 2019 Q1 | 2.84 Million GBP | 0.0% |
| 2019 FY | 12.46 Million GBP | 9.13% |
| 2019 Q2 | 3.19 Million GBP | 12.3% |
| 2018 Q3 | 4.63 Million GBP | 0.0% |
| 2018 Q1 | 4.63 Million GBP | 102.54% |
| 2018 Q4 | 2.84 Million GBP | -38.64% |
| 2018 FY | 11.42 Million GBP | 21.61% |
| 2017 Q2 | 2.12 Million GBP | 0.0% |
| 2017 Q4 | 2.28 Million GBP | 7.75% |
| 2017 Q3 | 2.12 Million GBP | 0.0% |
| 2017 FY | 9.39 Million GBP | 20.26% |
| 2016 Q1 | 1.65 Million GBP | 0.0% |
| 2016 Q3 | 1.54 Million GBP | 0.0% |
| 2016 Q2 | 1.54 Million GBP | -6.54% |
| 2016 FY | 7.81 Million GBP | 36.95% |
| 2015 FY | 5.7 Million GBP | 47.06% |
| 2015 Q1 | 1.15 Million GBP | 0.0% |
| 2015 Q2 | 1.19 Million GBP | 4.3% |
| 2015 Q3 | 1.19 Million GBP | 0.0% |
| 2015 Q4 | 1.65 Million GBP | 37.72% |
| 2014 Q1 | 1.25 Million GBP | 1635.2% |
| 2014 Q4 | 1.15 Million GBP | 45.75% |
| 2014 Q3 | 788.99 Thousand GBP | 0.0% |
| 2014 FY | 3.87 Million GBP | 11.28% |
| 2014 Q2 | 788.99 Thousand GBP | -37.28% |
| 2013 Q2 | 687 Thousand GBP | 917.79% |
| 2013 Q3 | 687 Thousand GBP | 0.0% |
| 2013 FY | 3.48 Million GBP | 36.37% |
| 2013 Q1 | 67.49 Thousand GBP | 0.0% |
| 2013 Q4 | 72.49 Thousand GBP | -89.45% |
| 2012 Q4 | 67.49 Thousand GBP | -88.01% |
| 2012 FY | 2.55 Million GBP | 2065.72% |
| 2012 Q2 | 563 Thousand GBP | 0.0% |
| 2012 Q3 | 563 Thousand GBP | 0.0% |
| 2011 FY | 118 Thousand GBP | -95.86% |
| 2010 FY | 2.84 Million GBP | -33.75% |
| 2009 FY | 4.29 Million GBP | -27.64% |
| 2008 FY | 5.94 Million GBP | -68.4% |
| 2007 FY | 18.8 Million GBP | 201.75% |
| 2006 FY | 6.23 Million GBP | -55.58% |
| 2005 FY | 14.02 Million GBP | 0.0% |
| 2004 FY | 14.02 Million GBP | 383.16% |
| 2003 FY | 2.9 Million GBP | 48483.33% |
| 2002 FY | -6000.00 GBP | -103.24% |
| 2001 FY | 185 Thousand GBP | 166.79% |
| 2000 FY | -277 Thousand GBP | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -1935.367% |
| Arrayit Corporation | 6.19 Million USD | -244.506% |
| Atlantic International Corp. | 5.57 Million USD | -282.753% |
| Biocept, Inc. | 29.4 Million USD | 27.38% |
| Bioqual, Inc. | 7.44 Million USD | -186.638% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -2665.165% |
| DermTech, Inc. | 104.01 Million USD | 79.473% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 87.177% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 5.625% |
| iMD Companies, Inc. | 151.8 Thousand USD | -13964.384% |
| IDenta Corp. | 662.97 Thousand USD | -3120.483% |
| Interpace Biosciences, Inc. | 20.23 Million USD | -5.531% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -54813.711% |
| InVitro International | 661.32 Thousand USD | -3128.523% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -200.803% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -36641.121% |
| Medical Imaging Corp. | 1.91 Million USD | -1016.588% |
| NovelStem International Corp. | 3.53 Million USD | -503.511% |
| Optigenex Inc. | 1.28 Million USD | -1557.855% |
| PharmChem, Inc. | 2.93 Million USD | -628.398% |
| Proteome Sciences plc | 3.26 Million USD | -553.335% |
| Response Genetics, Inc | 25.31 Million USD | 15.672% |
| Rennova Health, Inc. | 7.67 Million USD | -178.088% |
| RushNet, Inc. | 1.78 Million USD | -1093.247% |
| ScreenPro Security Inc. | 3.23 Million USD | -559.203% |
| Stella Diagnostics Inc. | 11.42 Million USD | -86.848% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -190.766% |
| Todos Medical Ltd. | 14.05 Million USD | -51.878% |